Association of Reproductive Health Professionals
Association of Reproductive Health Professionals
Reproductive Health Topics Publications & Resources Professional Education Newsroom Membership Policy & Advocacy About Us
CME/CE Opportunities - By FORMAT
Send To A Friend Send To A Friend Bookmark this Page Share this page

Vaginal Insert Therapies: Increasing Acceptance by Patients and Providers

This is an internet-based activity that should take 1 hour to complete.

To participate in this webinar learners should:

  1. Take the pretest
  2. Listen to webinar
  3. Take the post-test
  4. Complete follow-up evaluation survey

Learning Objectives

At the conclusion of this program, participants should be able to:

  • Increase the likelihood that your patients should appropriately select, adhere to, and be satisfied with their vaginal insert therapies
  • Discuss vaginal insert therapies when counseling your patients about their contraceptive options
  • Discuss vaginal insert therapies when counseling your patients about their options for treatment of vulvovaginal atrophy and menopausal symptoms
  • Recognize and address barriers to effective communication, thereby minimizing patient and provider discomfort when discussing vaginal insert therapies

Accreditation Information


The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

ARHP designates this internet enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Nurses:

This activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for up to 1.0 contact hour, including up to 0.5 pharmacology hours. Credit can be applied toward the nursing continuing requirements of most professional organizations and State Boards of Nursing.


A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 CreditTM

Sponsoring Information

This program is sponsored by the Association of Reproductive Health Professionals.

Funding Information

This project is funded through an unrestricted educational grant from Merck & Co., Inc. 

Disclosure Information

All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

Advisory Committee Disclosures

Sheryl A. Kingsberg, PhD

Chief, Division of Behavioral Medicine
University Hospitals Case Medical Center
MacDonald Women’s Hospital

Dr. Kingsberg consultant for Boehringer Ingelheim and Wyeth Pharmaceuticals.  She is a speaker for Eli Lilly and Company and Johnson and Johnson.

Anne Katz, RN, PhD

Clinical Nurse Specialist
CancerCare Manitoba

Dr. Katz has nothing to disclose.

Susan Goodman, MD, MPH
Associate Clinical Professor
Department of Family and Community Medicine
University of California San Francisco

Dr. Goodman has nothing to disclose.

ARHP Staff/Consultant Disclosures

Ellen L. Cohen, CertEd, DipEd

Director of Education

Nothing to disclose

Camille V. Harris, MPH

Program Manager

Nothing to Disclose

Beth Jordan, MD

Medical Director

Nothing to disclose

Wayne Shields

President and CEO

Nothing to disclose